Plain-English translation of NCT06593041 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand why blood platelets (tiny cells that help with clotting) become overactive in people with lupus and other autoimmune diseases. By studying blood samples from patients with lupus, scleroderma, vasculitis, myositis, Sjögren's syndrome, and rheumatoid arthritis, they hope to discover how platelets interact with immune cells and make inflammation worse—and potentially find new ways to treat these conditions.
Current treatments for lupus and related autoimmune diseases don't work well enough for everyone. Recent research suggests that overactive blood platelets may be driving the immune system to attack the body; if doctors can block this process, they might have a new way to help patients feel better.
You likely qualify if…
You likely don't qualify if…
You will visit the study site and have blood samples drawn—similar to a standard blood test. The researchers will analyze your blood to see how your platelets and immune cells interact. The study involves 450 participants total with various autoimmune diseases, and participation is primarily about providing these blood samples to advance understanding of how these diseases work.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
France